Onercept | Interleukin Related interleukin-related.com

Product Name :
Onercept

Search keywords :
Onercept

drugId :
null

Target Vo:
Tumor necrosis factor

Target Vo Short Name :
TNF

Moa_Name:
Tumor necrosis factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Weizmann Institute Of Science

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Plaque psoriasis

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD68 Antibody (YA529)
AGEs Antibody
Ki-67 Antibody: Ki-67 Antibody is an unconjugated, approximately 358 kDa, rabbit-derived, anti-Ki-67 polyclonal antibody. Ki-67 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, background without labeling.

Author: Interleukin Related

Related Posts